… differentiation of CSCs. When the cells are committed to differentiation, they cannot initiate
tumor growth … of CD51 could be a therapeutic target for restricting progression of prostate …

… promotes cancer stem cell renewal, cell proliferation and differentiation, … target genes provides
a reasonable explanation for how Wnt allows CSC mutations during cancer progression. It …

… curative therapy for heart failure is available, co-morbidities influence disease progression …
, we propose that GDF15 may be a valuable therapeutic target in heart failure as it is involved …

… during the cancer progression and have the potential to be targeted for anticancer therapy.
… signals mediating crosstalk of CAFs with cancer cells and its related targets or trials. Further, …

… regulating cancer progression and influencing therapeutic … treatment, strategies to target
the TME have expanded … , which may determine differential therapeutic efficacy, with the latter …

… from targeting recruitment and differentiation to functional … as therapeutic tools and targets
in cancer therapy, including … , antibiotic treatment can have dual effects on tumour growth …

… targets in the study of tumor biology and oncology therapies [… The stem cell differentiation
mechanism is highly controlled … to tumor progression enable specific therapeutic strategies for …

… and differentiation potential that contribute to tumor progression and therapy resistance. …
The eventual goal is to investigate why CSCs can escape treatment, be retained, and form a …

… The expression of MDK was correlated with poor tumor cell differentiation (poorly
differentiated tumor cells-weak MDK expression) in ESCC [124]. High serum MDK levels were …

… modulate inflammation in cancer therapy, with … tumor development and inflammatory
processes. We also highlight potential targets for harnessing inflammation in the treatment of cancer…